- Sweeping Health Care Overhaul Bill Passes House
- For the Jobless, 10% is Harder Than Before
- Week Ahead: Stocks Search for Catalyst in Quiet Week
- Outlook: Dollar to Ride Higher on Bleak Jobs Report
- Geithner: More Stimulus, Not a Bank Tax
- Windfall is Seen as Bank Bonuses are Paid in Stock
- Volatility Returns: Sign of the Bull Losing Muscle?
- Cramer: Earnings, IPOs Dominate Next Week
- Buying Fear: How to Own Volatility
- Food Network, HGTV Drive Scripps Networks' Upside Surprise
- Tommy Lee, Medical Tourism and Nasty Santa, Your Emails
- U.S. Markets Gain 3% for the Week Despite 10.2% Unemployment
- Disney's 'Carol' Tests Widest 3-D Release Ever
- Stimulus II? Jobs Tax Credit=Cash For Clunkers
- Rockwell Automation Earnings: What Options Are Saying
- Gold Will Touch Higher Lows and Higher Highs: Analyst
- Is Misery Alive And Well in Your Office?
- Consumers Haven't Changed, They Are Just Pickier
- Christmas comes early: ‘Carol’ tops box office
- Stock volatility is back, a sign of an aging bull?
- Philly transit strike in 6th day; no new talks
- Obama says it's now Senate's turn on health care
- Dubai says it has repaid $1 billion aviation bond
- Indian PM hopes for 7 percent growth next year
- Mexican magnate Bernardo Garza Sada dies at 79
- APEC leaders to push for new global economic plan
- Engine fire grounds Delta plane in Atlanta
Text Size 
CONSHOHOCKEN, Pa. - Wireless heart-monitoring device maker CardioNet Inc. fell to a loss in the third quarter, as it had ramped up marketing spending after Medicare lowered reimbursement rates on the company's products.
CardioNet said it lost $5.4 million, or 23 cents per share, company with a year-ago profit of $987,000, or 4 cents per share. Revenue grew 7 percent, to $33.3 million from $31.2 million.
However analysts were expecting a profit of 3 cents per share and revenue of $37.1 million.
Excluding restructuring charges, CardioNet said it lost $4.6 million. The company said patient volume rose 47 percent from a year ago, but that was mostly canceled out by lower Medicare payments.
On Sept. 1, Medicare administrator Highmark Medicare Service confirmed it would reduce the reimbursement rate on mobile heart technology, which includes CardioNet devices, to $754 per service. In response to the 33 percent cut, CardioNet said it needed to make new efforts to drive up sales and gain market share, as well as cut costs.
So far the company said it has eliminated $8 million in spending for 2010.
In aftermarket trading, CardioNet stock lost 46 cents, or 8.3 percent, to $5.09 from an earlier close at $5.55. Shares have traded between $5.07 and $29.50 over the last year.
Print
Email
- Rumors abound that Oprah will leave her show to start a new network. What would this mean for daytime TV?
- A private equity specialist sponsored a stand-up comedy troupe in New York to prove that CEOs can, in fact, be funny.
- Cramer did the research and found eight stocks that lead the pack. Read on to get his top picks.
- Did Hideki Matsui’s performance make it more likely that the Yankees will pay to have him back?
- Which wines should you bring—or serve—with holiday meals this year? Ask a connoisseur.
- Two competitors in this year’s World Series of Poker in Las Vegas have stories fit for Hollywood.
Data is a real-time snapshot *Data is delayed at least 15 minutes